nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—CYP26A1—embryo—testicular cancer	0.035	0.162	CbGeAlD
Acitretin—RBP1—embryo—testicular cancer	0.0209	0.0967	CbGeAlD
Acitretin—RBP1—gonad—testicular cancer	0.0142	0.0656	CbGeAlD
Acitretin—RXRA—female gonad—testicular cancer	0.0119	0.0549	CbGeAlD
Acitretin—RBP1—female gonad—testicular cancer	0.0115	0.0533	CbGeAlD
Acitretin—RARB—female gonad—testicular cancer	0.0107	0.0493	CbGeAlD
Acitretin—RBP1—testis—testicular cancer	0.0102	0.0473	CbGeAlD
Acitretin—RARA—gonad—testicular cancer	0.0101	0.0466	CbGeAlD
Acitretin—RXRB—female gonad—testicular cancer	0.00979	0.0453	CbGeAlD
Acitretin—RXRG—testis—testicular cancer	0.00924	0.0428	CbGeAlD
Acitretin—RARG—female gonad—testicular cancer	0.00869	0.0402	CbGeAlD
Acitretin—RXRB—testis—testicular cancer	0.00869	0.0402	CbGeAlD
Acitretin—RARA—female gonad—testicular cancer	0.00817	0.0378	CbGeAlD
Acitretin—RARG—testis—testicular cancer	0.00771	0.0357	CbGeAlD
Acitretin—RBP1—lymph node—testicular cancer	0.0074	0.0343	CbGeAlD
Acitretin—RARA—testis—testicular cancer	0.00725	0.0336	CbGeAlD
Acitretin—RARB—lymph node—testicular cancer	0.00685	0.0317	CbGeAlD
Acitretin—RARG—lymph node—testicular cancer	0.00559	0.0259	CbGeAlD
Acitretin—RARA—lymph node—testicular cancer	0.00525	0.0243	CbGeAlD
Acitretin—ALB—testis—testicular cancer	0.00409	0.0189	CbGeAlD
Acitretin—ALB—lymph node—testicular cancer	0.00296	0.0137	CbGeAlD
Acitretin—Pain—Cisplatin—testicular cancer	0.000581	0.000742	CcSEcCtD
Acitretin—Dermatitis—Bleomycin—testicular cancer	0.000581	0.000742	CcSEcCtD
Acitretin—Hypersensitivity—Ifosfamide—testicular cancer	0.000581	0.000741	CcSEcCtD
Acitretin—Muscular weakness—Doxorubicin—testicular cancer	0.00058	0.00074	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.00058	0.00074	CcSEcCtD
Acitretin—Dysuria—Epirubicin—testicular cancer	0.000574	0.000732	CcSEcCtD
Acitretin—Stomatitis—Methotrexate—testicular cancer	0.00057	0.000727	CcSEcCtD
Acitretin—Conjunctivitis—Methotrexate—testicular cancer	0.000569	0.000725	CcSEcCtD
Acitretin—Asthenia—Ifosfamide—testicular cancer	0.000566	0.000722	CcSEcCtD
Acitretin—Photosensitivity reaction—Epirubicin—testicular cancer	0.000561	0.000715	CcSEcCtD
Acitretin—Feeling abnormal—Cisplatin—testicular cancer	0.00056	0.000715	CcSEcCtD
Acitretin—Paraesthesia—Etoposide—testicular cancer	0.000559	0.000714	CcSEcCtD
Acitretin—Weight increased—Epirubicin—testicular cancer	0.000559	0.000713	CcSEcCtD
Acitretin—Pruritus—Ifosfamide—testicular cancer	0.000558	0.000712	CcSEcCtD
Acitretin—Haematuria—Methotrexate—testicular cancer	0.000558	0.000712	CcSEcCtD
Acitretin—Pancreatitis—Doxorubicin—testicular cancer	0.000557	0.000711	CcSEcCtD
Acitretin—Weight decreased—Epirubicin—testicular cancer	0.000556	0.000709	CcSEcCtD
Acitretin—Somnolence—Etoposide—testicular cancer	0.000554	0.000706	CcSEcCtD
Acitretin—Epistaxis—Methotrexate—testicular cancer	0.000552	0.000704	CcSEcCtD
Acitretin—Nausea—Bleomycin—testicular cancer	0.000548	0.000699	CcSEcCtD
Acitretin—Vomiting—Dactinomycin—testicular cancer	0.000547	0.000698	CcSEcCtD
Acitretin—Rash—Dactinomycin—testicular cancer	0.000543	0.000692	CcSEcCtD
Acitretin—Decreased appetite—Etoposide—testicular cancer	0.000542	0.000691	CcSEcCtD
Acitretin—Diarrhoea—Ifosfamide—testicular cancer	0.00054	0.000688	CcSEcCtD
Acitretin—Pancytopenia—Doxorubicin—testicular cancer	0.00054	0.000688	CcSEcCtD
Acitretin—Gastrointestinal disorder—Etoposide—testicular cancer	0.000538	0.000686	CcSEcCtD
Acitretin—Body temperature increased—Cisplatin—testicular cancer	0.000538	0.000686	CcSEcCtD
Acitretin—Fatigue—Etoposide—testicular cancer	0.000537	0.000685	CcSEcCtD
Acitretin—Neuropathy peripheral—Epirubicin—testicular cancer	0.000537	0.000685	CcSEcCtD
Acitretin—Jaundice—Epirubicin—testicular cancer	0.000534	0.000681	CcSEcCtD
Acitretin—Stomatitis—Epirubicin—testicular cancer	0.000534	0.000681	CcSEcCtD
Acitretin—Pain—Etoposide—testicular cancer	0.000533	0.00068	CcSEcCtD
Acitretin—Constipation—Etoposide—testicular cancer	0.000533	0.00068	CcSEcCtD
Acitretin—Urinary tract infection—Epirubicin—testicular cancer	0.000532	0.000679	CcSEcCtD
Acitretin—Conjunctivitis—Epirubicin—testicular cancer	0.000532	0.000679	CcSEcCtD
Acitretin—Dysuria—Doxorubicin—testicular cancer	0.000531	0.000678	CcSEcCtD
Acitretin—Haemoglobin—Methotrexate—testicular cancer	0.000528	0.000673	CcSEcCtD
Acitretin—Haemorrhage—Methotrexate—testicular cancer	0.000525	0.00067	CcSEcCtD
Acitretin—Hepatitis—Methotrexate—testicular cancer	0.000525	0.00067	CcSEcCtD
Acitretin—Haematuria—Epirubicin—testicular cancer	0.000522	0.000666	CcSEcCtD
Acitretin—Dizziness—Ifosfamide—testicular cancer	0.000522	0.000665	CcSEcCtD
Acitretin—Pharyngitis—Methotrexate—testicular cancer	0.000521	0.000665	CcSEcCtD
Acitretin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000519	0.000662	CcSEcCtD
Acitretin—Weight increased—Doxorubicin—testicular cancer	0.000517	0.00066	CcSEcCtD
Acitretin—Epistaxis—Epirubicin—testicular cancer	0.000516	0.000659	CcSEcCtD
Acitretin—Weight decreased—Doxorubicin—testicular cancer	0.000514	0.000656	CcSEcCtD
Acitretin—Sinusitis—Epirubicin—testicular cancer	0.000514	0.000655	CcSEcCtD
Acitretin—Feeling abnormal—Etoposide—testicular cancer	0.000513	0.000655	CcSEcCtD
Acitretin—Nausea—Dactinomycin—testicular cancer	0.000511	0.000652	CcSEcCtD
Acitretin—Gastrointestinal pain—Etoposide—testicular cancer	0.000509	0.00065	CcSEcCtD
Acitretin—Visual impairment—Methotrexate—testicular cancer	0.000506	0.000646	CcSEcCtD
Acitretin—Vomiting—Ifosfamide—testicular cancer	0.000502	0.00064	CcSEcCtD
Acitretin—Hypersensitivity—Cisplatin—testicular cancer	0.000501	0.000639	CcSEcCtD
Acitretin—Rash—Ifosfamide—testicular cancer	0.000497	0.000634	CcSEcCtD
Acitretin—Dermatitis—Ifosfamide—testicular cancer	0.000497	0.000634	CcSEcCtD
Acitretin—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000497	0.000633	CcSEcCtD
Acitretin—Urticaria—Etoposide—testicular cancer	0.000495	0.000631	CcSEcCtD
Acitretin—Haemoglobin—Epirubicin—testicular cancer	0.000494	0.00063	CcSEcCtD
Acitretin—Jaundice—Doxorubicin—testicular cancer	0.000494	0.00063	CcSEcCtD
Acitretin—Stomatitis—Doxorubicin—testicular cancer	0.000494	0.00063	CcSEcCtD
Acitretin—Rhinitis—Epirubicin—testicular cancer	0.000493	0.000629	CcSEcCtD
Acitretin—Abdominal pain—Etoposide—testicular cancer	0.000492	0.000628	CcSEcCtD
Acitretin—Body temperature increased—Etoposide—testicular cancer	0.000492	0.000628	CcSEcCtD
Acitretin—Conjunctivitis—Doxorubicin—testicular cancer	0.000492	0.000628	CcSEcCtD
Acitretin—Urinary tract infection—Doxorubicin—testicular cancer	0.000492	0.000628	CcSEcCtD
Acitretin—Hepatitis—Epirubicin—testicular cancer	0.000492	0.000627	CcSEcCtD
Acitretin—Haemorrhage—Epirubicin—testicular cancer	0.000492	0.000627	CcSEcCtD
Acitretin—Eye disorder—Methotrexate—testicular cancer	0.000491	0.000626	CcSEcCtD
Acitretin—Tinnitus—Methotrexate—testicular cancer	0.00049	0.000625	CcSEcCtD
Acitretin—Hypoaesthesia—Epirubicin—testicular cancer	0.000489	0.000624	CcSEcCtD
Acitretin—Asthenia—Cisplatin—testicular cancer	0.000488	0.000622	CcSEcCtD
Acitretin—Pharyngitis—Epirubicin—testicular cancer	0.000488	0.000622	CcSEcCtD
Acitretin—Oedema peripheral—Epirubicin—testicular cancer	0.000484	0.000618	CcSEcCtD
Acitretin—Haematuria—Doxorubicin—testicular cancer	0.000483	0.000616	CcSEcCtD
Acitretin—Epistaxis—Doxorubicin—testicular cancer	0.000478	0.00061	CcSEcCtD
Acitretin—Angiopathy—Methotrexate—testicular cancer	0.000477	0.000608	CcSEcCtD
Acitretin—Sinusitis—Doxorubicin—testicular cancer	0.000475	0.000606	CcSEcCtD
Acitretin—Immune system disorder—Methotrexate—testicular cancer	0.000474	0.000605	CcSEcCtD
Acitretin—Visual impairment—Epirubicin—testicular cancer	0.000474	0.000604	CcSEcCtD
Acitretin—Chills—Methotrexate—testicular cancer	0.000471	0.000601	CcSEcCtD
Acitretin—Nausea—Ifosfamide—testicular cancer	0.000469	0.000598	CcSEcCtD
Acitretin—Diarrhoea—Cisplatin—testicular cancer	0.000465	0.000593	CcSEcCtD
Acitretin—Alopecia—Methotrexate—testicular cancer	0.000464	0.000592	CcSEcCtD
Acitretin—Eye disorder—Epirubicin—testicular cancer	0.000459	0.000586	CcSEcCtD
Acitretin—Hypersensitivity—Etoposide—testicular cancer	0.000459	0.000585	CcSEcCtD
Acitretin—Tinnitus—Epirubicin—testicular cancer	0.000458	0.000585	CcSEcCtD
Acitretin—Erythema—Methotrexate—testicular cancer	0.000457	0.000583	CcSEcCtD
Acitretin—Haemoglobin—Doxorubicin—testicular cancer	0.000457	0.000583	CcSEcCtD
Acitretin—Flushing—Epirubicin—testicular cancer	0.000456	0.000582	CcSEcCtD
Acitretin—Rhinitis—Doxorubicin—testicular cancer	0.000456	0.000582	CcSEcCtD
Acitretin—Haemorrhage—Doxorubicin—testicular cancer	0.000455	0.00058	CcSEcCtD
Acitretin—Hepatitis—Doxorubicin—testicular cancer	0.000455	0.00058	CcSEcCtD
Acitretin—Hypoaesthesia—Doxorubicin—testicular cancer	0.000453	0.000577	CcSEcCtD
Acitretin—Pharyngitis—Doxorubicin—testicular cancer	0.000451	0.000576	CcSEcCtD
Acitretin—Oedema peripheral—Doxorubicin—testicular cancer	0.000448	0.000571	CcSEcCtD
Acitretin—Dysgeusia—Methotrexate—testicular cancer	0.000448	0.000571	CcSEcCtD
Acitretin—Asthenia—Etoposide—testicular cancer	0.000447	0.00057	CcSEcCtD
Acitretin—Angiopathy—Epirubicin—testicular cancer	0.000446	0.000569	CcSEcCtD
Acitretin—Immune system disorder—Epirubicin—testicular cancer	0.000444	0.000566	CcSEcCtD
Acitretin—Back pain—Methotrexate—testicular cancer	0.000442	0.000564	CcSEcCtD
Acitretin—Chills—Epirubicin—testicular cancer	0.000441	0.000563	CcSEcCtD
Acitretin—Pruritus—Etoposide—testicular cancer	0.000441	0.000562	CcSEcCtD
Acitretin—Visual impairment—Doxorubicin—testicular cancer	0.000438	0.000559	CcSEcCtD
Acitretin—Alopecia—Epirubicin—testicular cancer	0.000434	0.000554	CcSEcCtD
Acitretin—Vomiting—Cisplatin—testicular cancer	0.000432	0.000551	CcSEcCtD
Acitretin—Vision blurred—Methotrexate—testicular cancer	0.000431	0.00055	CcSEcCtD
Acitretin—Rash—Cisplatin—testicular cancer	0.000429	0.000547	CcSEcCtD
Acitretin—Dermatitis—Cisplatin—testicular cancer	0.000428	0.000546	CcSEcCtD
Acitretin—Erythema—Epirubicin—testicular cancer	0.000428	0.000546	CcSEcCtD
Acitretin—Diarrhoea—Etoposide—testicular cancer	0.000426	0.000544	CcSEcCtD
Acitretin—Eye disorder—Doxorubicin—testicular cancer	0.000425	0.000542	CcSEcCtD
Acitretin—Ill-defined disorder—Methotrexate—testicular cancer	0.000424	0.000541	CcSEcCtD
Acitretin—Tinnitus—Doxorubicin—testicular cancer	0.000424	0.000541	CcSEcCtD
Acitretin—Flushing—Doxorubicin—testicular cancer	0.000422	0.000538	CcSEcCtD
Acitretin—Tension—Epirubicin—testicular cancer	0.00042	0.000536	CcSEcCtD
Acitretin—Dysgeusia—Epirubicin—testicular cancer	0.000419	0.000534	CcSEcCtD
Acitretin—Nervousness—Epirubicin—testicular cancer	0.000416	0.00053	CcSEcCtD
Acitretin—Back pain—Epirubicin—testicular cancer	0.000414	0.000528	CcSEcCtD
Acitretin—Angiopathy—Doxorubicin—testicular cancer	0.000413	0.000526	CcSEcCtD
Acitretin—Malaise—Methotrexate—testicular cancer	0.000412	0.000526	CcSEcCtD
Acitretin—Dizziness—Etoposide—testicular cancer	0.000412	0.000525	CcSEcCtD
Acitretin—Muscle spasms—Epirubicin—testicular cancer	0.000411	0.000525	CcSEcCtD
Acitretin—Immune system disorder—Doxorubicin—testicular cancer	0.000411	0.000524	CcSEcCtD
Acitretin—Chills—Doxorubicin—testicular cancer	0.000408	0.000521	CcSEcCtD
Acitretin—Nausea—Cisplatin—testicular cancer	0.000404	0.000515	CcSEcCtD
Acitretin—Vision blurred—Epirubicin—testicular cancer	0.000403	0.000514	CcSEcCtD
Acitretin—Alopecia—Doxorubicin—testicular cancer	0.000402	0.000513	CcSEcCtD
Acitretin—Cough—Methotrexate—testicular cancer	0.000399	0.000509	CcSEcCtD
Acitretin—Ill-defined disorder—Epirubicin—testicular cancer	0.000397	0.000506	CcSEcCtD
Acitretin—Vomiting—Etoposide—testicular cancer	0.000396	0.000505	CcSEcCtD
Acitretin—Erythema—Doxorubicin—testicular cancer	0.000396	0.000505	CcSEcCtD
Acitretin—Rash—Etoposide—testicular cancer	0.000393	0.000501	CcSEcCtD
Acitretin—Dermatitis—Etoposide—testicular cancer	0.000392	0.000501	CcSEcCtD
Acitretin—Headache—Etoposide—testicular cancer	0.00039	0.000498	CcSEcCtD
Acitretin—Chest pain—Methotrexate—testicular cancer	0.000389	0.000497	CcSEcCtD
Acitretin—Arthralgia—Methotrexate—testicular cancer	0.000389	0.000497	CcSEcCtD
Acitretin—Myalgia—Methotrexate—testicular cancer	0.000389	0.000497	CcSEcCtD
Acitretin—Tension—Doxorubicin—testicular cancer	0.000388	0.000496	CcSEcCtD
Acitretin—Dysgeusia—Doxorubicin—testicular cancer	0.000388	0.000495	CcSEcCtD
Acitretin—Malaise—Epirubicin—testicular cancer	0.000386	0.000492	CcSEcCtD
Acitretin—Discomfort—Methotrexate—testicular cancer	0.000385	0.000491	CcSEcCtD
Acitretin—Nervousness—Doxorubicin—testicular cancer	0.000385	0.00049	CcSEcCtD
Acitretin—Back pain—Doxorubicin—testicular cancer	0.000383	0.000488	CcSEcCtD
Acitretin—Muscle spasms—Doxorubicin—testicular cancer	0.000381	0.000486	CcSEcCtD
Acitretin—Cough—Epirubicin—testicular cancer	0.000373	0.000476	CcSEcCtD
Acitretin—Vision blurred—Doxorubicin—testicular cancer	0.000373	0.000476	CcSEcCtD
Acitretin—Infection—Methotrexate—testicular cancer	0.000371	0.000473	CcSEcCtD
Acitretin—Nausea—Etoposide—testicular cancer	0.00037	0.000472	CcSEcCtD
Acitretin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000367	0.000469	CcSEcCtD
Acitretin—Chest pain—Epirubicin—testicular cancer	0.000364	0.000465	CcSEcCtD
Acitretin—Arthralgia—Epirubicin—testicular cancer	0.000364	0.000465	CcSEcCtD
Acitretin—Myalgia—Epirubicin—testicular cancer	0.000364	0.000465	CcSEcCtD
Acitretin—Anxiety—Epirubicin—testicular cancer	0.000363	0.000463	CcSEcCtD
Acitretin—Skin disorder—Methotrexate—testicular cancer	0.000362	0.000462	CcSEcCtD
Acitretin—Hyperhidrosis—Methotrexate—testicular cancer	0.000361	0.00046	CcSEcCtD
Acitretin—Discomfort—Epirubicin—testicular cancer	0.00036	0.000459	CcSEcCtD
Acitretin—Malaise—Doxorubicin—testicular cancer	0.000357	0.000455	CcSEcCtD
Acitretin—Dry mouth—Epirubicin—testicular cancer	0.000356	0.000454	CcSEcCtD
Acitretin—Anorexia—Methotrexate—testicular cancer	0.000356	0.000454	CcSEcCtD
Acitretin—Oedema—Epirubicin—testicular cancer	0.000349	0.000445	CcSEcCtD
Acitretin—Infection—Epirubicin—testicular cancer	0.000347	0.000443	CcSEcCtD
Acitretin—Cough—Doxorubicin—testicular cancer	0.000345	0.000441	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00034	0.000434	CcSEcCtD
Acitretin—Skin disorder—Epirubicin—testicular cancer	0.000339	0.000433	CcSEcCtD
Acitretin—Hyperhidrosis—Epirubicin—testicular cancer	0.000338	0.000431	CcSEcCtD
Acitretin—Insomnia—Methotrexate—testicular cancer	0.000337	0.00043	CcSEcCtD
Acitretin—Chest pain—Doxorubicin—testicular cancer	0.000337	0.00043	CcSEcCtD
Acitretin—Arthralgia—Doxorubicin—testicular cancer	0.000337	0.00043	CcSEcCtD
Acitretin—Myalgia—Doxorubicin—testicular cancer	0.000337	0.00043	CcSEcCtD
Acitretin—Anxiety—Doxorubicin—testicular cancer	0.000336	0.000428	CcSEcCtD
Acitretin—Paraesthesia—Methotrexate—testicular cancer	0.000335	0.000427	CcSEcCtD
Acitretin—Discomfort—Doxorubicin—testicular cancer	0.000333	0.000425	CcSEcCtD
Acitretin—Anorexia—Epirubicin—testicular cancer	0.000333	0.000425	CcSEcCtD
Acitretin—Somnolence—Methotrexate—testicular cancer	0.000332	0.000423	CcSEcCtD
Acitretin—Dry mouth—Doxorubicin—testicular cancer	0.00033	0.00042	CcSEcCtD
Acitretin—Dyspepsia—Methotrexate—testicular cancer	0.000328	0.000419	CcSEcCtD
Acitretin—Decreased appetite—Methotrexate—testicular cancer	0.000324	0.000414	CcSEcCtD
Acitretin—Oedema—Doxorubicin—testicular cancer	0.000323	0.000412	CcSEcCtD
Acitretin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000322	0.000411	CcSEcCtD
Acitretin—Fatigue—Methotrexate—testicular cancer	0.000322	0.00041	CcSEcCtD
Acitretin—Infection—Doxorubicin—testicular cancer	0.000321	0.000409	CcSEcCtD
Acitretin—Pain—Methotrexate—testicular cancer	0.000319	0.000407	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000318	0.000406	CcSEcCtD
Acitretin—Insomnia—Epirubicin—testicular cancer	0.000316	0.000403	CcSEcCtD
Acitretin—Skin disorder—Doxorubicin—testicular cancer	0.000314	0.0004	CcSEcCtD
Acitretin—Paraesthesia—Epirubicin—testicular cancer	0.000314	0.0004	CcSEcCtD
Acitretin—Hyperhidrosis—Doxorubicin—testicular cancer	0.000312	0.000398	CcSEcCtD
Acitretin—Somnolence—Epirubicin—testicular cancer	0.00031	0.000396	CcSEcCtD
Acitretin—Anorexia—Doxorubicin—testicular cancer	0.000308	0.000393	CcSEcCtD
Acitretin—Feeling abnormal—Methotrexate—testicular cancer	0.000307	0.000392	CcSEcCtD
Acitretin—Dyspepsia—Epirubicin—testicular cancer	0.000307	0.000392	CcSEcCtD
Acitretin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000305	0.000389	CcSEcCtD
Acitretin—Decreased appetite—Epirubicin—testicular cancer	0.000304	0.000387	CcSEcCtD
Acitretin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000301	0.000385	CcSEcCtD
Acitretin—Fatigue—Epirubicin—testicular cancer	0.000301	0.000384	CcSEcCtD
Acitretin—Pain—Epirubicin—testicular cancer	0.000299	0.000381	CcSEcCtD
Acitretin—Constipation—Epirubicin—testicular cancer	0.000299	0.000381	CcSEcCtD
Acitretin—Urticaria—Methotrexate—testicular cancer	0.000296	0.000378	CcSEcCtD
Acitretin—Abdominal pain—Methotrexate—testicular cancer	0.000295	0.000376	CcSEcCtD
Acitretin—Body temperature increased—Methotrexate—testicular cancer	0.000295	0.000376	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000294	0.000375	CcSEcCtD
Acitretin—Insomnia—Doxorubicin—testicular cancer	0.000292	0.000373	CcSEcCtD
Acitretin—Paraesthesia—Doxorubicin—testicular cancer	0.00029	0.00037	CcSEcCtD
Acitretin—Feeling abnormal—Epirubicin—testicular cancer	0.000288	0.000367	CcSEcCtD
Acitretin—Somnolence—Doxorubicin—testicular cancer	0.000287	0.000366	CcSEcCtD
Acitretin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000286	0.000364	CcSEcCtD
Acitretin—Dyspepsia—Doxorubicin—testicular cancer	0.000284	0.000363	CcSEcCtD
Acitretin—Decreased appetite—Doxorubicin—testicular cancer	0.000281	0.000358	CcSEcCtD
Acitretin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000279	0.000356	CcSEcCtD
Acitretin—Fatigue—Doxorubicin—testicular cancer	0.000279	0.000355	CcSEcCtD
Acitretin—Urticaria—Epirubicin—testicular cancer	0.000277	0.000354	CcSEcCtD
Acitretin—Constipation—Doxorubicin—testicular cancer	0.000276	0.000352	CcSEcCtD
Acitretin—Pain—Doxorubicin—testicular cancer	0.000276	0.000352	CcSEcCtD
Acitretin—Body temperature increased—Epirubicin—testicular cancer	0.000276	0.000352	CcSEcCtD
Acitretin—Abdominal pain—Epirubicin—testicular cancer	0.000276	0.000352	CcSEcCtD
Acitretin—Hypersensitivity—Methotrexate—testicular cancer	0.000275	0.000351	CcSEcCtD
Acitretin—Asthenia—Methotrexate—testicular cancer	0.000268	0.000341	CcSEcCtD
Acitretin—Feeling abnormal—Doxorubicin—testicular cancer	0.000266	0.00034	CcSEcCtD
Acitretin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000264	0.000337	CcSEcCtD
Acitretin—Pruritus—Methotrexate—testicular cancer	0.000264	0.000337	CcSEcCtD
Acitretin—Hypersensitivity—Epirubicin—testicular cancer	0.000257	0.000328	CcSEcCtD
Acitretin—Urticaria—Doxorubicin—testicular cancer	0.000257	0.000327	CcSEcCtD
Acitretin—Abdominal pain—Doxorubicin—testicular cancer	0.000255	0.000326	CcSEcCtD
Acitretin—Body temperature increased—Doxorubicin—testicular cancer	0.000255	0.000326	CcSEcCtD
Acitretin—Diarrhoea—Methotrexate—testicular cancer	0.000255	0.000326	CcSEcCtD
Acitretin—Asthenia—Epirubicin—testicular cancer	0.000251	0.00032	CcSEcCtD
Acitretin—Pruritus—Epirubicin—testicular cancer	0.000247	0.000315	CcSEcCtD
Acitretin—Dizziness—Methotrexate—testicular cancer	0.000247	0.000315	CcSEcCtD
Acitretin—Diarrhoea—Epirubicin—testicular cancer	0.000239	0.000305	CcSEcCtD
Acitretin—Hypersensitivity—Doxorubicin—testicular cancer	0.000238	0.000304	CcSEcCtD
Acitretin—Vomiting—Methotrexate—testicular cancer	0.000237	0.000303	CcSEcCtD
Acitretin—Rash—Methotrexate—testicular cancer	0.000235	0.0003	CcSEcCtD
Acitretin—Dermatitis—Methotrexate—testicular cancer	0.000235	0.0003	CcSEcCtD
Acitretin—Headache—Methotrexate—testicular cancer	0.000234	0.000298	CcSEcCtD
Acitretin—Asthenia—Doxorubicin—testicular cancer	0.000232	0.000296	CcSEcCtD
Acitretin—Dizziness—Epirubicin—testicular cancer	0.000231	0.000295	CcSEcCtD
Acitretin—Pruritus—Doxorubicin—testicular cancer	0.000229	0.000292	CcSEcCtD
Acitretin—Vomiting—Epirubicin—testicular cancer	0.000222	0.000283	CcSEcCtD
Acitretin—Nausea—Methotrexate—testicular cancer	0.000222	0.000283	CcSEcCtD
Acitretin—Diarrhoea—Doxorubicin—testicular cancer	0.000221	0.000282	CcSEcCtD
Acitretin—Rash—Epirubicin—testicular cancer	0.00022	0.000281	CcSEcCtD
Acitretin—Dermatitis—Epirubicin—testicular cancer	0.00022	0.000281	CcSEcCtD
Acitretin—Headache—Epirubicin—testicular cancer	0.000219	0.000279	CcSEcCtD
Acitretin—Dizziness—Doxorubicin—testicular cancer	0.000214	0.000273	CcSEcCtD
Acitretin—Nausea—Epirubicin—testicular cancer	0.000207	0.000265	CcSEcCtD
Acitretin—Vomiting—Doxorubicin—testicular cancer	0.000205	0.000262	CcSEcCtD
Acitretin—Rash—Doxorubicin—testicular cancer	0.000204	0.00026	CcSEcCtD
Acitretin—Dermatitis—Doxorubicin—testicular cancer	0.000204	0.00026	CcSEcCtD
Acitretin—Headache—Doxorubicin—testicular cancer	0.000202	0.000258	CcSEcCtD
Acitretin—Nausea—Doxorubicin—testicular cancer	0.000192	0.000245	CcSEcCtD
